Meletios- Athanasios Dimopoulos (Meletios A Dimopoulos, Meletios Dimopoulos, Meletios A Dimopoulos, Meletios Athanasios Dimopoulos, Meletios-Athanasios Dimopoulos, Dimopoulos Meletios Athanasios, Meletios Athanassios Dimopoulos)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 264

Top Venues

American journal of hematology

Blood cancer journal

Cancers

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

National and Kapodistrian University of Athens

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens Aug 01 1994

Greece

Professor :: Department of Clinical Therapeutics

Publications

Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Katja Weisel, Meletios- Athanasios Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden, Joseph Mikhael
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison. Leukemia & lymphoma 65 (4) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Katja Weisel, Meletios- Athanasios Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden, Joseph Mikhael
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison. Leukemia & lymphoma 65 (4) (2024)
Ioanna E Stergiou, Christos Tsironis, Stavros P Papadakos, Ourania E Tsitsilonis, Meletios- Athanasios Dimopoulos, Stamatios Theocharis
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies. International journal of molecular sciences 25 (4) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Sosana Delimpasi, Meletios- Athanasios Dimopoulos, Jan Straub, Argiris Symeonidis, Luděk Pour, Roman Hájek, Cyrille Touzeau, Viralkumar K Bhanderi, Jesus G Berdeja, Petr Pavlíček, Jeffrey V Matous, Pawel J Robak, Kaveri Suryanarayan, Alison Miller, Miguel Villarreal, Dasha Cherepanov, Jaydeep K Srimani, Huilan Yao, Richard Labotka, Robert Z Orlowski
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma. American journal of hematology (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology 204 (5) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Katja Weisel, Meletios- Athanasios Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden, Joseph Mikhael
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison. Leukemia & lymphoma (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Prashant Kapoor, Nitya Nathwani, Tomas Jelinek, Ludek Pour, Aurore Perrot, Meletios- Athanasios Dimopoulos, Shang-Yi Huang, Ivan Spicka, Saurabh Chhabra, Eben Lichtman, Maria-Victoria Mateos, Dheepak Kanagavel, Liang Zhao, Helene Guillemin-Paveau, Sandrine Macé, Helgi van de Velde, Paul Gerard Richardson
An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma. European journal of haematology (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, Aristea-Maria Papanota, Panagiotis G Adamopoulos, Ioannis Ntanasis-Stathopoulos, Christine-Ivy Liacos, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF HisGTG results in patients' poor treatment outcome. British journal of haematology (2024)
Sosana Delimpasi, Meletios- Athanasios Dimopoulos, Jan Straub, Argiris Symeonidis, Luděk Pour, Roman Hájek, Cyrille Touzeau, Viralkumar K Bhanderi, Jesus G Berdeja, Petr Pavlíček, Jeffrey V Matous, Pawel J Robak, Kaveri Suryanarayan, Alison Miller, Miguel Villarreal, Dasha Cherepanov, Jaydeep K Srimani, Huilan Yao, Richard Labotka, Robert Z Orlowski
Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma. American journal of hematology 99 (9) (2024)
Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Evangelos Terpos
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma. American journal of hematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Ioanna Tatouli, Nikolaos Dedes, Andreas Bozikas, Stamatoula Melliou, Maria-Markella Pavlou, Sofoklis Kontogiannis, Efthymios Kyrodimos, Eftychia Kanioura, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos, George Dimopoulos, Efstathios Kastritis, Maria Gavriatopoulou
Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR Acinetobacter baumannii and Literature Review. Microorganisms 12 (7) (2024)
Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, Ioannis Ntanasis-Stathopoulos, Fryni Karaolidou, Annita-Ioanna Gkioka, Vasiliki Labropoulou, Emmanouil Spanoudakis, Theodora Triantafyllou, Maria Kotsopoulou, Eyrydiki Michalis, Chrysanthi Vadikolia, Theodosia Papadopoulou, Aggeliki Sevastoudi, Michael Michael, Aikaterini Daiou, Aikaterini Pentidou, Ioannis V Kostopoulos, Vasiliki Palaska, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Evgenia Verrou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group. American journal of hematology (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Katja Weisel, Meletios- Athanasios Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden, Joseph Mikhael
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison. Leukemia & lymphoma 65 (4) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, Aristea-Maria Papanota, Panagiotis G Adamopoulos, Ioannis Ntanasis-Stathopoulos, Christine-Ivy Liacos, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF HisGTG results in patients' poor treatment outcome. British journal of haematology 204 (5) (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Ioanna Tatouli, Nikolaos Dedes, Andreas Bozikas, Stamatoula Melliou, Maria-Markella Pavlou, Sofoklis Kontogiannis, Efthymios Kyrodimos, Eftychia Kanioura, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos, George Dimopoulos, Efstathios Kastritis, Maria Gavriatopoulou
Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR Acinetobacter baumannii and Literature Review. Microorganisms 12 (7) (2024)
Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Ioanna E Stergiou, Christos Tsironis, Stavros P Papadakos, Ourania E Tsitsilonis, Meletios- Athanasios Dimopoulos, Stamatios Theocharis
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies. International journal of molecular sciences 25 (4) (2024)
Ioanna Tatouli, Nikolaos Dedes, Andreas Bozikas, Stamatoula Melliou, Maria-Markella Pavlou, Sofoklis Kontogiannis, Efthymios Kyrodimos, Eftychia Kanioura, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos, George Dimopoulos, Efstathios Kastritis, Maria Gavriatopoulou
Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR Acinetobacter baumannii and Literature Review. Microorganisms 12 (7) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Angeliki Andrikopoulou, Garyfalia Bletsa, Angeliki Rouvalis, Dimitrios Tsakogiannis, Maria Kaparelou, Alkistis Papatheodoridi, Dimitrios Haidopoulos, Michalis Liontos, Meletios- Athanasios Dimopoulos, Flora Zagouri
The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer. Cancers 16 (11) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Angeliki Andrikopoulou, Garyfalia Bletsa, Angeliki Rouvalis, Dimitrios Tsakogiannis, Maria Kaparelou, Alkistis Papatheodoridi, Dimitrios Haidopoulos, Michalis Liontos, Meletios- Athanasios Dimopoulos, Flora Zagouri
The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer. Cancers 16 (11) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Ioanna E Stergiou, Christos Tsironis, Stavros P Papadakos, Ourania E Tsitsilonis, Meletios- Athanasios Dimopoulos, Stamatios Theocharis
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies. International journal of molecular sciences 25 (4) (2024)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Evangelos Terpos, Asimina Papanikolaou, Charikleia Gakiopoulou, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies. European journal of haematology (2023)
Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Sonja Zweegman, Marc-Steffen Raab, Markus Munder, Lucia Pantani, Katia Mancuso, Peter Brossart, Meral Beksac, Igor W Blau, Jan Dürig, Britta Besemer, Roland Fenk, Peter Reimer, Bronno van der Holt, Mathias Hänel, Ivana von Metzler, Ullrich Graeven, Carsten Muller-Tidow, Mario Boccadoro, Christof Scheid, Meletios- Athanasios Dimopoulos, Jens Hillengass, Katja C Weisel, Michele Cavo, Pieter Sonneveld, Hartmut Goldschmidt
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients. Leukemia (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Alkistis Papatheodoridi, Eleni Papamattheou, Spyridon Marinopoulos, Ioannis Ntanasis-Stathopoulos, Constantine Dimitrakakis, Aris Giannos, Maria Kaparelou, Michalis Liontos, Meletios- Athanasios Dimopoulos, Flora Zagouri
Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature. Medical sciences (Basel, Switzerland) 11 (2) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Lisa B Leypoldt, Maria Gavriatopoulou, Britta Besemer, Hans J Salwender, Marc S Raab, Axel Nogai, Cyrus Khandanpour, Volker Runde, Anna Jauch, Manola Zago, Peter Martus, Hartmut Goldschmidt, Carsten Bokemeyer, Meletios- Athanasios Dimopoulos, Katja C Weisel
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial. Cancers 15 (18) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Vasiliki Labropoulou, Sosana Delimpasi, Katia Mancuso, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie-Christine Kyrtsonis, Maria Roussou, Despina Fotiou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Giorgos Cheliotis, Kyriaki Manousou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study. American journal of hematology (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Angeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, Maria Kaparelou, Konstantinos Koutsoukos, Kleoniki Apostolidou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios- Athanasios Dimopoulos, Flora Zagouri, Michalis Liontos
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer. Cancers 15 (13) (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Vasiliki Gkalea, Despina Fotiou, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Monoclonal Gammopathy of Thrombotic Significance. Cancers 15 (2) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Stephen Samuel Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn Engelbrekt Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Veronique Leblond, Steven P Treon, Judith Trotman, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S Tam
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Efstathia Liatsou, Ioanna Tatouli, Andreas Mpozikas, Maria-Markella Pavlou, Hariklia Gakiopoulou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Sofoklis Kontogiannis, Meletios- Athanasios Dimopoulos
Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection. Journal of clinical medicine 12 (22) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Ioanna Barla, Panagiotis Efentakis, Sofia Lamprou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Ioanna Andreadou, Νikolaos S Τhomaidis, Evangelos Gikas
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation. International journal of molecular sciences 24 (18) (2023)
Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, Panagiotis Malandrakis, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era. Diseases (Basel, Switzerland) 11 (3) (2023)
Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Maria Gavriatopoulou
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma. International journal of molecular sciences 24 (14) (2023)
Meletios- Athanasios Dimopoulos, Jesús San F Miguel
Reply to S. Al Hadidi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (9) (2023)
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis-Stathopoulos, Annita-Ioanna Gkioka, Nikos Giannakoulas, Nikolaos Kanellias, Theodosia Papadopoulou, Aggeliki Sevastoudi, Eyrydiki Michalis, Maria Papathanasiou, Maria Kotsopoulou, Anastasia Sioni, Theodora Triantafyllou, Aikaterini Daiou, Mavra Papadatou, Marie-Christine Kyrtsonis, Anastasia Pouli, Ioannis V Kostopoulos, Evgenia Verrou, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group. American journal of hematology (2023)
Vasiliki Gkalea, Despina Fotiou, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Monoclonal Gammopathy of Thrombotic Significance. Cancers 15 (2) (2023)
Ioanna E Stergiou, Stavros P Papadakos, Anna Karyda, Ourania E Tsitsilonis, Meletios- Athanasios Dimopoulos, Stamatios Theocharis
EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. Cancers 15 (15) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Christian Buske, Meletios- Athanasios Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cécile Tomowiak, Béatrice Mahé, Xavier Troussard, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, Hacene Zerazhi, Benedicte Hivert, Veronique Leblond, Sophie de Guibert, Lena Brandefors, Miriam Santero, Maria Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Christian Buske, Meletios- Athanasios Dimopoulos, Pierre Morel, null null
Reply to S. Sarosiek et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Meletios- Athanasios Dimopoulos, Stephen Samuel Opat, Steven P Treon, Constantine S Tam
Reply to Y. Song et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Efthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, Christos Markellos, Savvina Moustafa, Dimitrios Pectasides, Meletios- Athanasios Dimopoulos, Flora Zagouri, Dimitrios Vassilopoulos
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting. The breast journal 2023 (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Foteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, Maria Roussou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Asimina Papanikolaou, Maria Gavriatopoulou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy. British journal of haematology (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Santhi Devasundaram, Evangelos Terpos, Margherita Rosati, Ioannis Ntanasis-Stathopoulos, Jenifer Bear, Robert Burns, Stamatia Skourti, Panagiotis Malandrakis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1. American journal of hematology (2023)
Santhi Devasundaram, Evangelos Terpos, Margherita Rosati, Ioannis Ntanasis-Stathopoulos, Jenifer Bear, Robert Burns, Stamatia Skourti, Panagiotis Malandrakis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1. American journal of hematology (2023)
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, Foteini Theodorakakou, Despina Fotiou, Shahrier Hossain, Sean Rowell, Houry Leblebjian, Eileen Regan, Peter Czarnecki, Filippo Bagnoli, Niccolo' Bolli, Paul Gerard Richardson, Helmut G Rennke, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis-Stathopoulos, Annita-Ioanna Gkioka, Nikos Giannakoulas, Nikolaos Kanellias, Theodosia Papadopoulou, Aggeliki Sevastoudi, Eyrydiki Michalis, Maria Papathanasiou, Maria Kotsopoulou, Anastasia Sioni, Theodora Triantafyllou, Aikaterini Daiou, Mavra Papadatou, Marie-Christine Kyrtsonis, Anastasia Pouli, Ioannis V Kostopoulos, Evgenia Verrou, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Improved Survival of Patients with Primary Plasma Cell Leukemia with VRd or Daratumumab-based Quadruplets: A Multicenter Study by the Greek Myeloma Study Group. American journal of hematology (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Meletios- Athanasios Dimopoulos.css-eqlu8i{font-size:small;padding-left:4px;} (Meletios A Dimopoulos, Meletios Dimopoulos, Meletios A Dimopoulos, Meletios Athanasios Dimopoulos, Meletios-Athanasios Dimopoulos, Dimopoulos Meletios Athanasios, Meletios Athanassios Dimopoulos)

Publication Activity (10 Years)

Top Topics

Top Venues

Meletios- Athanasios Dimopoulos (Meletios A Dimopoulos, Meletios Dimopoulos, Meletios A Dimopoulos, Meletios Athanasios Dimopoulos, Meletios-Athanasios Dimopoulos, Dimopoulos Meletios Athanasios, Meletios Athanassios Dimopoulos)